Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 143.60
-11.90 (-7.65%)
Aug 3, 2026, 5:24 PM IDT
Evogene Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1.84 | 3.85 | 5.58 | 2.98 | 1.68 | 0.93 |
Revenue Growth | -72.74% | -30.91% | 87.02% | 78.03% | 80.11% | -10.58% |
Gross Profit Gross Profit Growth | -0.86 | -0.24 | 3.2 | 1.49 | 0.77 | 0.16 |
Operating Income Operating Income Growth | -13.75 | -13.79 | -18.29 | -22.23 | -26.94 | -30.95 |
Net Income Net Income Growth | -11.77 | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 |
Earnings Per Share EPS Growth | -1.37 | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Agriculture Agriculture Growth | 1.37 | 2.96 | 1.13 | 0.88 | 0.63 |
Industrial Applications Industrial Applications Growth | 2.17 | 2.22 | 1.08 | 0.07 | 0.04 |
Human Health Human Health Growth | - | 0.08 | 0.49 | 0.51 | 0.18 |
Unallocated Unallocated Growth | 0.31 | 0.32 | 0.29 | 0.21 | 0.08 |
Total Total Growth | 3.85 | 5.58 | 2.98 | 1.68 | 0.93 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13.05 | 12.96 | 15.3 | 31.06 | 35.36 | 53.87 |
Total Debt Total Debt Growth | 2.03 | 2.2 | 2.5 | 1.14 | 1.82 | 2.67 |
Net Cash (Debt) Net Cash Growth | 11.02 | 10.76 | 12.8 | 29.93 | 33.54 | 51.2 |
Net Cash Growth | 51.90% | -15.94% | -57.23% | -10.78% | -34.49% | 11.81% |
Net Cash Per Share Net Cash Per Share Growth | 1.28 | 1.37 | 2.25 | 6.52 | 8.10 | 12.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -11.27 | -13.5 | -19.7 | -21.58 | -23.68 | -24.72 |
Capital Expenditures CapEx Growth | -0.02 | -0.14 | -0.63 | -0.58 | -1.17 | -0.85 |
Free Cash Flow Free Cash Flow Growth | -11.29 | -13.64 | -20.33 | -22.15 | -24.85 | -25.56 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -46.80% | -6.25% | 57.33% | 50.03% | 45.73% | 17.53% |
Operating Margin | -745.66% | -357.85% | -327.95% | -745.51% | -1608.42% | -3328.28% |
Pretax Margin | -949.08% | -350.32% | -265.52% | -735.95% | -1776.36% | -3272.26% |
Profit Margin | -638.18% | -220.22% | -295.59% | -800.77% | -1590.33% | -2988.49% |
FCF Margin | -612.26% | -353.93% | -364.46% | -742.92% | -1483.52% | -2748.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 2.60 | 2.13 | 2.33 | 14.11 | 15.64 | 76.49 |